Acute Kidney Injury Treatment Market by Product, Injury Type, End-User - Global Forecast 2025-2030- Product Image

Sale

Acute Kidney Injury Treatment Market by Product, Injury Type, End-User - Global Forecast 2025-2030

Report
182 Pages
October 2024
Region: Global
360iResearch™
ID: 5134204

UP TO €692EUR$697USD£576GBP OFF until Dec 31^st 2024

The Acute Kidney Injury Treatment Market grew from USD 1.87 billion in 2023 to USD 2.02 billion in 2024. It is expected to continue growing at a CAGR of 7.81%, reaching USD 3.17 billion by 2030.

Acute Kidney Injury (AKI), a sudden deterioration of kidney function, demands diligent attention given its life-threatening nature and rising incidence globally. The scope of AKI treatment encompasses early diagnosis, prevention, therapeutic intervention, and management strategies aimed at restoring renal function. Treatment options range from pharmaceutical approaches such as diuretics, dialysis, and renal replacement therapies, to newer innovations like regenerative medicine and biomarkers for early detection. The necessity for effective AKI treatment is underscored by its association with high mortality rates and significant healthcare expenditures. This application finds substantial utility in hospitals, specialty clinics, and research institutes, with pharmaceutical companies and healthcare providers being primary end-users. Key growth influencers include the increasing prevalence of chronic conditions like diabetes and hypertension, advancements in renal care technologies, and heightened awareness regarding early intervention and personalized medicine. Moreover, the aging population further exacerbates the demand for effective AKI treatments, presenting lucrative opportunities for market players. However, notable challenges such as high treatment costs, complex pathophysiology, and lack of adequate diagnostic tools pose hurdles to market expansion. Regulatory approvals and reimbursement issues also impede rapid product commercialization. To capture emerging opportunities, businesses could focus on collaborations for research in biomarkers that facilitate early detection, along with the development of cost-effective therapeutic solutions. Innovation areas such as artificial intelligence in predictive analytics for early AKI risk stratification and personalized treatment protocols present viable prospects. Market insights reveal a competitive landscape driven by continuous innovation and a strategic focus on expanding product pipelines, especially in underexplored regions. Overall, a multifaceted approach involving technological advancement, strategic partnerships, and market diversification is recommended to overcome current limitations, ensuring robust market growth and enhanced patient outcomes in the AKI treatment domain.

Understanding Market Dynamics in the Acute Kidney Injury Treatment Market

The Acute Kidney Injury Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Rising number of kidney failures and kidney-related diseases
- Growing number of drug approvals for the treatment of kidney disorders
- Government initiatives to raise awareness about kidney health
Market Restraints
- High cost of availing treatment and lack of reimbursements
Market Opportunities
- Advancements to enhance kidney treatment options and improve disease detection
- New hospitals providing kidney treatment and improvements in outpatient care
Market Challenges
- Stringent regulations concerning certain kidney injury treatment options

Exploring Porter’s Five Forces for the Acute Kidney Injury Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Acute Kidney Injury Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Acute Kidney Injury Treatment Market

External macro-environmental factors deeply influence the performance of the Acute Kidney Injury Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Acute Kidney Injury Treatment Market

The Acute Kidney Injury Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Acute Kidney Injury Treatment Market

The Acute Kidney Injury Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Acute Kidney Injury Treatment Market

The Acute Kidney Injury Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Acute Kidney Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alloksys Life Sciences B.V., Amgen Inc., Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bayer AG, bioMérieux SA, Dr. Reddys Laboratories Ltd., Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Reata Pharmaceuticals Inc. by Biogen Inc., Rockwell Medical, Inc., Silver Creek Pharmaceuticals, Inc., Stealth BioTherapeutics, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Dialysis
  - Continuous Renal Replacement Therapy (CRRT)
  - Intermittent Hemodialysis
  - Sustained Low-Efficiency Dialysis (SLED)
- Drug Therapy
  - Antibiotics
  - Diuretics
  - Immunosuppressive Agents
Injury Type
- Intrinsic-Renal Acute Kidney Injury
- Post-Renal Acute Kidney Injury
- Pre-Renal Acute Kidney Injury
End-User
- Ambulatory Surgical Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of kidney failures and kidney-related diseases
5.1.1.2. Growing number of drug approvals for the treatment of kidney disorders
5.1.1.3. Government initiatives to raise awareness about kidney health
5.1.2. Restraints
5.1.2.1. High cost of availing treatment and lack of reimbursements
5.1.3. Opportunities
5.1.3.1. Advancements to enhance kidney treatment options and improve disease detection
5.1.3.2. New hospitals providing kidney treatment and improvements in outpatient care
5.1.4. Challenges
5.1.4.1. Stringent regulations concerning certain kidney injury treatment options
5.2. Market Segmentation Analysis
5.2.1. Product: Rising number of research initiatives to improve dialysis treatment
5.2.2. Injury type: Awareness about underlying causes of kidney injury leading to the creation of treatments for Intrinsic-Renal Acute Kidney Injury
5.2.3. End-user: Improvements in outpatient care leading to rising prevalence of ambulatory surgical centers (ASCs)
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Acute Kidney Injury Treatment Market, by Product

6.1. Introduction
6.2. Dialysis
6.2.1. Continuous Renal Replacement Therapy (CRRT)
6.2.2. Intermittent Hemodialysis
6.2.3. Sustained Low-Efficiency Dialysis (SLED)
6.3. Drug Therapy
6.3.1. Antibiotics
6.3.2. Diuretics
6.3.3. Immunosuppressive Agents

7. Acute Kidney Injury Treatment Market, by Injury Type

7.1. Introduction
7.2. Intrinsic-Renal Acute Kidney Injury
7.3. Post-Renal Acute Kidney Injury
7.4. Pre-Renal Acute Kidney Injury

8. Acute Kidney Injury Treatment Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Acute Kidney Injury Treatment Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Acute Kidney Injury Treatment Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Novartis to Buy Chinook for Up to USD 3.5 Billion, Expanding Kidney Disease Pipeline
12.3.2. CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
12.3.3. SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. ACUTE KIDNEY INJURY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ACUTE KIDNEY INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ACUTE KIDNEY INJURY TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY SUSTAINED LOW-EFFICIENCY DIALYSIS (SLED), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTRINSIC-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY POST-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRE-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 43. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 44. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 49. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 70. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 71. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 75. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 76. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 85. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 86. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 115. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 116. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 129. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 131. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 136. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 137. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 141. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 142. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 147. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 152. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 161. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 162. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 177. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 181. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 182. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 186. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 187. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 206. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 207. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 221. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 222. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 235. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Acute Kidney Injury Treatment Market, which are profiled in this report, include:

Abbott Laboratories
Alloksys Life Sciences B.V.
Amgen Inc.
Angion Biomedica Corp.
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Baxter International, Inc.
Bayer AG
bioMérieux SA
Dr. Reddys Laboratories Ltd.
Fresenius Medical Care AG & Co. KGaA
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Pfizer Inc.
Reata Pharmaceuticals Inc. by Biogen Inc.
Rockwell Medical, Inc.
Silver Creek Pharmaceuticals, Inc.
Stealth BioTherapeutics, Inc.
Teva Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.02 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.17 Billion
Compound Annual Growth Rate	7.8%
Regions Covered	Global
No. of Companies Mentioned	22

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3522EUR$3,545USD£2,928GBP €3913EUR$3,939USD£3,254GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6231EUR$6,272USD£5,181GBP €6923EUR$6,969USD£5,757GBP

Understanding Market Dynamics in the Acute Kidney Injury Treatment Market

Exploring Porter’s Five Forces for the Acute Kidney Injury Treatment Market

Applying PESTLE Analysis to the Acute Kidney Injury Treatment Market

Analyzing Market Share in the Acute Kidney Injury Treatment Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Acute Kidney Injury Treatment Market

Strategic Recommendations for Success in the Acute Kidney Injury Treatment Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Acute Kidney Injury Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024-2032

Acute Kidney Injury (AKI) - Market Insight, Epidemiology and Market Forecast - 2032

Acute Kidney Injury - Pipeline Insight, 2024

2024 Global Forecast for Acute Kidney Injury Treatment (2025-2030 Outlook)-High Tech & Emerging Markets Report

Renal Failure Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

About the Renal Failure Drug Market